TickerFacts.

Revelation Biosciences, Inc. (REVB): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$18.34M
Year ended 2024-12-31
2021-12-31: -$11.22M2024-12-31: -$18.34M-$18.34M
2021-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$18.34Mn/a2026-02-26, From 2024-01-01
No annual figure between 2021-12-31 and 2024-12-31.
2021-12-31-$11.22Mn/a2023-03-30, From 2021-01-01